198 related articles for article (PubMed ID: 22320925)
1. Morphogens and hepatic stellate cell fate regulation in chronic liver disease.
Tsukamoto H; Zhu NL; Wang J; Asahina K; Machida K
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):94-8. PubMed ID: 22320925
[TBL] [Abstract][Full Text] [Related]
2. The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.
Zhu NL; Wang J; Tsukamoto H
J Biol Chem; 2010 Oct; 285(40):30463-71. PubMed ID: 20663865
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
Zhu NL; Asahina K; Wang J; Ueno A; Lazaro R; Miyaoka Y; Miyajima A; Tsukamoto H
J Biol Chem; 2012 Mar; 287(13):10355-10367. PubMed ID: 22298767
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
5. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.
Yang MD; Chiang YM; Higashiyama R; Asahina K; Mann DA; Mann J; Wang CC; Tsukamoto H
Hepatology; 2012 Apr; 55(4):1271-81. PubMed ID: 22095555
[TBL] [Abstract][Full Text] [Related]
6. Morphogen-related therapeutic targets for liver fibrosis.
Fung E; Tsukamoto H
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S69-74. PubMed ID: 26206577
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic cell fate regulation of hepatic stellate cells.
Tsukamoto H; Zhu NL; Asahina K; Mann DA; Mann J
Hepatol Res; 2011 Jul; 41(7):675-82. PubMed ID: 21504520
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.
Choi SS; Omenetti A; Witek RP; Moylan CA; Syn WK; Jung Y; Yang L; Sudan DL; Sicklick JK; Michelotti GA; Rojkind M; Diehl AM
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1093-106. PubMed ID: 19815628
[TBL] [Abstract][Full Text] [Related]
9. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.
Zhang F; Kong D; Lu Y; Zheng S
Cell Mol Life Sci; 2013 Jan; 70(2):259-76. PubMed ID: 22699820
[TBL] [Abstract][Full Text] [Related]
11. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming and cell fate regulation in alcoholic liver disease.
Tsukamoto H
Pancreatology; 2015 Jul; 15(4 Suppl):S61-5. PubMed ID: 25800177
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
Huang J; Yu X; Fries JW; Zhang L; Odenthal M
Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
[TBL] [Abstract][Full Text] [Related]
15. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.
Choi SS; Syn WK; Karaca GF; Omenetti A; Moylan CA; Witek RP; Agboola KM; Jung Y; Michelotti GA; Diehl AM
J Biol Chem; 2010 Nov; 285(47):36551-60. PubMed ID: 20843817
[TBL] [Abstract][Full Text] [Related]
16. Adipogenic transcriptional regulation of hepatic stellate cells.
She H; Xiong S; Hazra S; Tsukamoto H
J Biol Chem; 2005 Feb; 280(6):4959-67. PubMed ID: 15537655
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-β receptor in hepatic stellate cells.
Zhang F; Kong D; Chen L; Zhang X; Lian N; Zhu X; Lu Y; Zheng S
J Cell Sci; 2014 Jan; 127(Pt 2):305-14. PubMed ID: 24259663
[TBL] [Abstract][Full Text] [Related]
18. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation.
Tsukamoto H; She H; Hazra S; Cheng J; Miyahara T
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S102-5. PubMed ID: 16958658
[TBL] [Abstract][Full Text] [Related]
19. GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation.
Zhou Q; Guan W; Qiao H; Cheng Y; Li Z; Zhai X; Zhou Y
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2367-77. PubMed ID: 25305367
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
